ID: ALA5188998

Max Phase: Preclinical

Molecular Formula: C13H9N3O2

Molecular Weight: 239.23

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccncc1)c1noc2ccccc12

Standard InChI:  InChI=1S/C13H9N3O2/c17-13(15-9-5-7-14-8-6-9)12-10-3-1-2-4-11(10)18-16-12/h1-8H,(H,14,15,17)

Standard InChI Key:  OLDOAIHQBYYJCF-UHFFFAOYSA-N

Associated Targets(Human)

Hypoxia-inducible factor 1 alpha 6027 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 239.23Molecular Weight (Monoisotopic): 239.0695AlogP: 2.48#Rotatable Bonds: 2
Polar Surface Area: 68.02Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.49CX Basic pKa: 5.56CX LogP: 1.62CX LogD: 1.61
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.75Np Likeness Score: -1.74

References

1. Xue Z, Li H, Xie W, Xu Y, Zhou L, Qu ZB..  (2022)  Benzo[d]isoxazole Derivatives as Hypoxia-Inducible Factor (HIF)-1α Inhibitors.,  13  (12.0): [PMID:36518694] [10.1021/acsmedchemlett.2c00308]

Source